share_log
Moomoo 24/7 ·  Nov 28, 2023 06:47
NanoViricides Has Completed The Single-ascending Dose Part Of The Phase 1A/1B Human Trial Of NV-COV-2, A Broad-spectrum Antiviral Drug, Recruitment For The Multiple-ascending Dose Part Was Also Completed
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment